In the previous SPRINT study, researchers compared an intensive BP reduction strategy (target systolic BP <120 mmHg) vs standard BP reduction strategy (target systolic BP <140 mmHg).
For more details about differences in stroke risk, prevention, and treatment in women, Neurology Advisor spoke with Elisabeth B. Marsh, MD, from Johns Hopkins School of Medicine and Kristy Yuan, MD, from the University of Pennsylvania.
Antihypertensive treatments during delivery hospitalizations in women with preeclampsia have increased.
Stimulation of the other brain structures resulted in no significant blood pressure changes among the studied participants.
The new guidelines for the diagnostic threshold for stage 1 hypertension were lowered from 140/90 to 130/80.
Patients at risk of stroke may benefit from the total homocysteine-lowering effects of folic acid supplementation.
While the increase in cardiovascular risk factors is at least partially due to the obesity epidemic, the researchers believe the increase is multifactorial.
There was no correlation for early-adulthood hypertension with dementia, although among women these effect estimates were elevated.
Previous reports have suggested that statins or the low levels of LDL cholesterol they promote may have an adverse impact on cognition.
Findings from this trial challenge current recommended systolic blood pressure targets for older adults.
There is a higher risk of all-cause dementia, vascular dementia, and Alzheimer's disease in the elderly with increased BP variability.
Although spot sign predicted ICH expansion, it proved to be a less robust diagnostic marker than demonstrated by previous single-center cohort studies.
Dr Pamela Rist, of Harvard Medical School, discusses her research in women with migraine and hypertension at the 2017 American Academy of Neurology Annual Meeting in Boston, MA. Scroll to below the video for a full text transcript of Dr Rist's interview.
Mortality among women with preeclampsia and pregnancy-associated stroke was significantly higher than in controls.
Women with a history of migraine are at increased risk for developing hypertension.
A committee from the American Heart Association failed to make specific clinical recommendations for the management of hypertension related to cognitive impairment.
There was no difference in risk of stroke or mortality between hypertensive groups.
A joint medical and surgical approach may ensure the best outcome.
Abnormal vital signs in these patients may be more common than previously thought.
Those whose blood pressure rose steeply in middle age had the highest risk of stroke.
Women who had high blood pressure while pregnant demonstrated later cognitive impairment and smaller brain volume compared with women who had normotensive pregnancies.
Adherence to at least one of the treatments reduced risk of fatal stroke.
The prediction of events was more robust with home readings compared with clinic readings.
Over the follow-up period, hypertension prevalence increased from 9% to 28% in the cohort.
Lowering blood pressure is associated with decreased risk of coronary heart disease, stroke, and heart failure.
A lower blood pressure target may help prevent cardiovascular events and reduce all-cause mortality.
CPAP has a much higher probability of being the most strongly associated with SBP reduction.
A drop in blood pressure upon standing could be a sign of a degenerative brain disease such as Parkinson's or dementia.
Findings from diffusion tensor imaging and cognitive assessment allowed for the evaluation of impairment.
Poor management of blood pressure post-ICH could raise the risk of recurrence.
Neurology Advisor Articles
- Higher Levels of Cholesterol May Protect Men From Parkinson Disease
- Early Clinical Traits of Multiple Sclerosis Prodrome Identified
- Chronic Pain May Be Contributor to Suicide
- Ajovy Injection Approved for Migraine Prevention in Adults
- FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Brivaracetam Effective for Reducing Seizures in Patients with Epileptic Encephalopathies
- Familial Hemiplegic Migraine Attacks May Be Associated With Cortical Swelling
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Fremanezumab May Have Long-Term Efficacy as a Prophylactic for Chronic Migraine
- Propofol May Decrease Delay in Neurocognitive Recovery